Research And Development Expense of Legend Biotech Corp from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
ifrs-full: USD
Summary
Legend Biotech Corp quarterly and annual Research And Development Expense in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • Legend Biotech Corp Research And Development Expense for the quarter ending 31 Dec 2025 was $101,326,000, a 2.9% decline year-over-year.
  • Legend Biotech Corp Research And Development Expense for the twelve months ending 31 Dec 2025 was $414,700,000, a 0.29% increase year-over-year.
  • Legend Biotech Corp annual Research And Development Expense for 2025 was $414,700,000, a 0.29% increase from 2024.
  • Legend Biotech Corp annual Research And Development Expense for 2024 was $413,500,000, a 8.2% increase from 2023.
  • Legend Biotech Corp annual Research And Development Expense for 2023 was $382,200,000, a 14% increase from 2022.
Source SEC data
View on sec.gov
Research And Development Expense, Trailing 12 Months (USD)
Research And Development Expense, Quarterly (USD)
Research And Development Expense, YoY Quarterly Change (%)
Research And Development Expense, Annual (USD)
Research And Development Expense, YoY Annual Change (%)

Legend Biotech Corp Quarterly Research And Development Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $414,700,000 $101,326,000 -$3,062,000 -2.9% 01 Oct 2025 31 Dec 2025 20-F 10 Mar 2026 2025 FY
Q3 2025 $417,762,000 $113,148,000 +$17,626,000 +18% 01 Jul 2025 30 Sep 2025 6-K 12 Nov 2025 2025 Q3
Q2 2025 $400,136,000 $98,302,000 -$14,324,000 -13% 01 Apr 2025 30 Jun 2025 6-K 11 Aug 2025 2025 Q2
Q1 2025 $414,460,000 $101,924,000 +$960,000 +0.95% 01 Jan 2025 31 Mar 2025 6-K 13 May 2025 2025 Q1
Q4 2024 $413,500,000 $104,388,000 01 Oct 2024 31 Dec 2024 20-F 10 Mar 2026 2025 FY
Q3 2024 $95,522,000 01 Jul 2024 30 Sep 2024 6-K 12 Nov 2025 2025 Q3
Q2 2024 $112,626,000 01 Apr 2024 30 Jun 2024 6-K 11 Aug 2025 2025 Q2
Q1 2024 $100,964,000 +$16,075,000 +19% 01 Jan 2024 31 Mar 2024 6-K 13 May 2025 2025 Q1
Q1 2023 $84,889,000 01 Jan 2023 31 Mar 2023 6-K 13 May 2024 2024 Q1

Legend Biotech Corp Annual Research And Development Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $414,700,000 +$1,200,000 +0.29% 01 Jan 2025 31 Dec 2025 20-F 10 Mar 2026 2025 FY
2024 $413,500,000 +$31,300,000 +8.2% 01 Jan 2024 31 Dec 2024 20-F 10 Mar 2026 2025 FY
2023 $382,200,000 +$46,552,000 +14% 01 Jan 2023 31 Dec 2023 20-F 10 Mar 2026 2025 FY
2022 $335,648,000 +$22,302,000 +7.1% 01 Jan 2022 31 Dec 2022 20-F 11 Mar 2025 2024 FY
2021 $313,346,000 +$81,186,000 +35% 01 Jan 2021 31 Dec 2021 20-F 19 Mar 2024 2023 FY
2020 $232,160,000 +$70,217,000 +43% 01 Jan 2020 31 Dec 2020 20-F 30 Mar 2023 2022 FY
2019 $161,943,000 +$101,306,000 +167% 01 Jan 2019 31 Dec 2019 20-F/A 17 Feb 2023 2021 FY
2018 $60,637,000 01 Jan 2018 31 Dec 2018 20-F 02 Apr 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.